Environmental-protection simple preparation method of teriflunomide

A technology of fluomibide and leflunomide, which is applied in the field of preparation of terimide, can solve the problems of increasing the cost of post-processing of industrial waste, and achieve the effects of convenient preparation method, short reaction steps, and easy industrial production.

Active Publication Date: 2016-01-27
CINKATE PHARMA INTERMEDIATES
View PDF11 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Rinse with a large amount of water after the reaction, and the mixture of organic solvent and water forms a large amount of waste liquid, which increases the post-treatment cost of industrial waste

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Environmental-protection simple preparation method of teriflunomide
  • Environmental-protection simple preparation method of teriflunomide
  • Environmental-protection simple preparation method of teriflunomide

Examples

Experimental program
Comparison scheme
Effect test

preparation example Construction

[0026] The preparation method of Terimide of the present invention uses eflunomide as a raw material to prepare Terimide through a ring-opening reaction and an acidification reaction, wherein the ring-opening reaction is carried out in an aqueous alkali solution.

[0027] The time for the ring-opening reaction is 1.5-4 hr, preferably 2-3 hr.

[0028] The method also includes the step of recrystallizing the tirimide obtained after the acidification reaction to obtain pure tirimide.

[0029] Described alkali is sodium hydroxide, potassium hydroxide.

[0030] The weight ratio of the leflunomide to the alkali aqueous solution is 1:15-1:35.

[0031] The weight ratio of the leflunomide to the alkali aqueous solution is 1:20-1:30.

[0032] The concentration of the alkali aqueous solution is 0.3-0.7 mol / L.

[0033] The concentration of the alkali aqueous solution is 0.4-0.6 mol / L, preferably 0.5 mol / L.

[0034] The temperature of the ring-opening reaction is 15-50°C.

[0035] The...

Embodiment 1

[0063] Preparation of Terimide

[0064] Weigh 9.6 g of sodium hydroxide, dissolve it in 480 ml of water at room temperature, and put 20 g of leflunomide into the sodium hydroxide solution. After stirring at room temperature for 2 hours, the end point of the reaction was determined by thin-layer chromatography. Add 240ml of water and continue stirring for 30min, and filter the insoluble matter.

[0065] Add 23.4ml of concentrated hydrochloric acid to the filtrate for acidification, and a white solid precipitates out immediately. Filter and dry to obtain the crude product of Terimite. The yield is 90-98%.

[0066] Add 240 ml of ethyl acetate to 15 g of the crude product of Terimide, reflux until dissolved, and cool down to crystallize. Filter and dry to obtain the pure product of Terimide with a purity ≥99.8% (HPLC).

[0067] MP: 228-232°C

[0068] Mass: 269(M + -1)

[0069] H-NMR(DMSO): δ2.265(s, 3H); 7.68(d, 2H); 7.76(d, 2H); 10.83(s, 1H)

[0070] IR: 3302, 2220, 1634...

Embodiment 2

[0072] Preparation of Terimide

[0073] Weigh 13.4 g of potassium hydroxide, dissolve it in 480 ml of water at room temperature, and put 20 g of leflunomide into the solution. After reacting at room temperature for 2 hours, TLC determined the reaction end point. Add 240ml of water and continue stirring for 30min, and filter the insoluble matter.

[0074] Add 23.4ml of concentrated hydrochloric acid to the filtrate for acidification, and a white solid precipitates out. Filter and dry to obtain the crude product of Terimite. The yield was 95-98%.

[0075] After recrystallization, the purity of Terimide is ≥99.8% (HPLC).

[0076] MP: 228-232°C

[0077] Mass: 269(M + -1)

[0078] H-NMR(DMSO): δ2.265(s, 3H); 7.68(d, 2H); 7.76(d, 2H); 10.83(s, 1H)

[0079] IR: 3302, 2220, 1634, 1593, 1552, 1419, 1324, 1247, 1158, 1114, 1072, 971, 843, 686cm -1 .

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses an environmental-protection simple preparation method of teriflunomide; leflunomide is used as a starting material, a heterogeneous reaction is adopted, an organic solvent is avoided from being used in a synthesis reaction process, and thus the high-purity teriflunomide can be prepared.

Description

technical field [0001] The invention relates to a preparation method of tirimide. Background technique [0002] Teriflunomide (Teriflunomide), chemical name: N-(4-trifluoromethylbenzene)-2-cyano-3-hydroxyl-2-butenamide, structure as shown in formula I, leflunomide The active metabolite is a dihydroorotate dehydrogenase (DHODH) inhibitor. Terimide was developed by Sanofi-Aventis and was approved by the FDA in September 2012. The indication is multiple sclerosis, and the trade name is Aubagio. [0003] [0004] There are two main routes for the synthesis of Terimide: [0005] (1) With p-trifluoromethylaniline as starting raw material, react with cyanoacetic acid to prepare amide, and then further react with CH by amide 3 The CO-group reacts to produce Terimide. Patents such as WO0056703, WO9954286, US2004186173, and US2004085383 all used this idea to synthesize Terimide. [0006] [0007] (2) Using eflunomide as the starting material, the ring-opening of isoxazole u...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): C07C255/23C07C253/00
Inventor 孙丽华袁西伦张丽娜肖飞
Owner CINKATE PHARMA INTERMEDIATES
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap